LEO Pharma’s Anzupgo® Gains MHRA Approval in Great Britain for Chronic Hand Eczema LEO Pharma has secured marketing authorisation from the MHRA for its innovative treatment, Anzupgo® (delgocitinib) cream, marking a breakthrough for adults with moderate to severe Chronic Hand Eczema ...

www.linkedin.com/pulse/leo-ph...

LEO Pharma’s Anzupgo® Gains MHRA Approval in Great Britain for Chronic Hand Eczema

#LEOPharma #ChronicHandEczema #AnzupgoCream #Delgocitinib #SkinHealth #NHSAccess #MedicalBreakthrough #HealthcareInnovation #Humanteconomy #Humantec